ENO2 and COVID-19: We aimed to investigate serum concentrations of biomarkers of neuronal (Neuro-Specific Enolase, NSE) and glial (S100-beta Protein, S100B) injuries, EEG alterations observed at the acute phase of severe COVID-19, and their association with short term outcomes (i.e. invasive mechanical ventilation and mortality at 90 days).